A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alizarin Red S | CAS 130-22-3 - Request Quote

Picture of Alizarin Red S

Alizarin Red S

SZ CAT No:SZ-M161558
CAS No
130-22-3
Mol.F.
C14H7O7S : Na
Mol.Wt.
319.3 : 23.0
Inv. Status
Synthesis on demand
Rel. CAS No83-61-4 (free base)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Alizarin Red S is chemically Sodium 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate. Alizarin Red S is supplied with detailed characterization data compliant with regulatory guideline. Alizarin Red S can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Miscellaneous-2.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 130-22-3

Purchase 130-22-3

Order 130-22-3

Enquire 130-22-3

price of 130-22-3

130-22-3 Supplier

130-22-3 Manufacturer

130-22-3 Exporter

buy high quality Alizarin Red S

Purchase Alizarin Red S

Alizarin Red S suppliers

Alizarin Red S manufacturers

Alizarin Red S price

Order Alizarin Red S

Enquire Alizarin Red S

Alizarin Red S cost

Alizarin Red S Supplier

Alizarin Red S Distributor

Alizarin Red S for Method Validation

Miscellaneous-2 Reference Standard

Alizarin Red S for ANDA Filing

Alizarin Red S for Forced Degradation Studies

Alizarin Red S Identification Standards

Alizarin Red S for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,